Zeta Stock Rockets 200% YTD: What’s Fueling The Surge? – Zeta Global Holdings (NYSE:ZETA)

Photo of author

By Ronald Tech

Zeta Global Holdings Corp. ZETA is riding a wave of investor enthusiasm, rallying 200% year-to-date.

The company also enjoyed a 108% year-over-year surge in platform usage during the Cyber Five period spanning Thanksgiving through Cyber Monday. This growth came as brands doubled down on Zeta’s omnichannel tools to deliver hyper-personalized marketing during the most critical shopping days of the year.

Brands use Zeta’s marketing platform “to engage high-intent shoppers” to deliver “exceptional efficiency and effective outcomes,” Zeta CEO David A. Steinberg says.

And the holiday buzz is far from over. A Zeta survey revealed that 53% of consumers plan to shop in December, up 8% from last year, pointing to sustained demand for digital marketing tools.

Read Also: Why Is Zeta Global Stock Soaring?

Zeta Stock Holds Firm In Bullish Territory.

Chart created using Benzinga Pro

ZETA’s share price of $26.29 sits comfortably above key moving averages:

  • Eight-day SMA: $23.48 (Bullish)
  • 20-day SMA: $23.56 (Bullish)
  • 200-day SMA: $19.95 (Bullish)

However, the 50-day SMA of $27.12 and a MACD indicator of a negative 0.61 flash a note of caution, suggesting slight selling pressure.

With an RSI of 54.18, ZETA stock is heading towards the overbought territory, hinting that momentum may need a breather.

Beyond The Holidays: The Long-Term Play

Zeta’s robust annual revenue growth forecast of 17.1% outpaces the U.S. market’s 8.9%. The company’s $100 million share repurchase program signals confidence in its long-term potential.

Investors are also keeping a close eye on Zeta’s projected 123.5% annual earnings growth, a statistic hard to ignore.

Zeta’s surge reflects its ability to capitalize on evolving consumer behaviors and deliver value through cutting-edge marketing tools. While near-term technicals show slight pressure, the stock’s long-term growth story remains compelling.

See also  <!DOCTYPE html><html lang="en"><head> <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <title>3 Stock Spinoffs Poised for Market Domination</title></head><body> <div> <h2>The Forgotten Gold Mine: Hidden Value in Spinoff Stocks</h2> <p>Spinoff stocks have long been cast aside by investors, deemed as unwanted remnants of bigger entities. However, diving deep into the world of spinoffs reveals a treasure trove waiting to be discovered. As investing guru Joel Greenblatt highlights in his timeless masterpiece "You Can Be a Stock Market Genius," these castaways often harbor unrealized potential when set free.</p> <h2>Solventum (SOLV): A Diamond in the Rough</h2> <p><strong>Solventum</strong> (NYSE:<span class="stock-ticker"><strong><u>SOLV</u></strong></span>) emerges as a promising player in the healthcare landscape after being spun off from industrial giant <strong>3M</strong> (NYSE:<span class="stock-ticker"><strong><u>MMM</u></strong></span>). With a stronghold in sterilization devices, dressings, tapes, this $8.2 billion revenue giant is ready to conquer. Despite a sluggish start post-separation, boasting revenues of $2 billion and $2.08 per share earnings, the stock remains undervalued. Priced at a discount due to an $8.3 billion debt burden from its previous parent, Solventum is on the path to redemption, making it a beacon in the sea of mediocrity.</p> <h2>Kenvue (KVUE): Unleashing Consumer Power</h2> <p><strong>Kenvue</strong> (NYSE:<span class="stock-ticker"><strong><u>KVUE</u></strong></span>) struts into the consumer health sector post its emancipation from <strong>Johnson & Johnson</strong> (NYSE:<span class="stock-ticker"><strong><u>JNJ</u></strong></span>). The custodian of iconic brands like Tylenol, Listerine, or Band-Aid, this $15 billion powerhouse flexes its muscles. With a formidable dividend legacy inherited from its erstwhile parent, Kenvue stands tall despite a 24% drop since its inception. Like a phoenix rising from the ashes, Kenvue is poised to soar high on the wings of trust and quality.</p> <h2>W.K. Kellogg (KLG): A Breakfast of Champions</h2> <p>If you had cereal for breakfast, chances are it bore the imprint of <strong>W.K. Kellogg</strong> (KLG). Stepping out of the shadows of its parent, this stalwart in the breakfast food industry is no stranger to your morning routine. With a legacy as rich as your favorite cornflakes, W.K. Kellogg is a stock to watch, destined to nurture portfolios much like it nurtures bodies.</p> </div></body></html><!DOCTYPE html><html><head> <title>The Rise of W.K. Kellogg in a Shrinking Cereal Market</title></head><body> The Rise of W.K. Kellogg in a Shrinking Cereal Market

Whether Zeta can sustain this momentum into 2025 depends on its ability to navigate market challenges and keep delivering for its enterprise clients.

Read Next:

Market News and Data brought to you by Benzinga APIs

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.